Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for Q0180. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
17
Median % of Medicare
--
Rate range
$54.99 - $117.15
Q0180 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Arizona | $60.32 | -- | -- | 2026 |
| Idaho | $87.47 | -- | Not required | 2025 |
| Illinois | $54.99 | -- | -- | 2026 |
| Kansas | $59.12 | -- | -- | 2024 |
| Massachusetts | $94.79 | -- | -- | 2026 |
| Montana | $117.15 | -- | -- | 2026 |
| Nebraska | $64.42 | -- | -- | 2026 |
| New Jersey | $66.71 | -- | Not required | 2026 |
| New Mexico | $107.32 | -- | -- | 2025 |
| Oklahoma | $59.12 | -- | -- | 2026 |
| Rhode Island | $69.03 | -- | -- | 2026 |
| South Carolina | $58.18 | -- | -- | 2024 |
| Texas | $60.31* | -- | -- | 2023 |
| Utah | $95.51* | -- | Not required | 2024 |
| Virginia | $101.23 | -- | -- | 2017 |
| Washington | $59.12 | -- | -- | 2026 |
| Wisconsin | $101.24 | -- | -- | 2017 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related state-specific services codes
- C1716 - Brachytherapy source, non-stranded, gold-198, per source
- C1717 - Brachytherapy source, non-stranded, high dose rate iridium-192, per source
- C1719 - Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
- C2616 - Brachytherapy source, non-stranded, yttrium-90, per source
- C2634 - Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source
- C2635 - Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source
- C2636 - Brachytherapy linear source, non-stranded, palladium-103, per 1 mm
- C2638 - Brachytherapy source, stranded, iodine-125, per source
All 52 codes from Q0035 to Q0506 or every state-specific services code by number.
Frequently asked questions
How much does Medicaid pay for Q0180?
17 state Medicaid programs publish a fee-for-service rate for Q0180 (dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen), ranging from $54.99 in Illinois to $117.15 in Montana. The full table on this page lists every publishing state's current rate.
Which state pays the most for Q0180?
Montana publishes the highest Medicaid rate for Q0180 at $117.15. Illinois publishes the lowest at $54.99.
Does Q0180 require prior authorization under Medicaid?
No publishing state flags Q0180 with a prior-authorization indicator on its fee schedule. Absence of a flag means the state publishes none, not that PA is never required - confirm through the state's provider manual.